B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MITOGEN-ACTIVATED

MOLECULAR TARGET

Mitogen-activated protein kinase 14 (human)

UniProt: Q1653914 compounds

MITOGEN-ACTIVATED (Mitogen-activated protein kinase 14 (human)) is targeted by 14 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MITOGEN-ACTIVATED

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1pd980591.956
2Dasatinib1.795
3Tripterygium1.614
4Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).1.393
5Hexachlorophene1.393
6sp6001251.393
7Crizotinib1.102
8Sorafenib1.102
917-alpha-Hydroxyprogesterone0.691
10Antimycin0.691
11Axitinib0.691
12Disulfiram0.691
13sulindac sulfide0.691
14Troglitazone0.691

About MITOGEN-ACTIVATED as a Drug Target

MITOGEN-ACTIVATED (Mitogen-activated protein kinase 14 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 14 compounds with documented MITOGEN-ACTIVATED interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MITOGEN-ACTIVATED inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.